000			02044 a2200541 4500
005			20250516103909.0
264		0	_c20130214
008			201302s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/j.1365-2141.2012.09247.x _2doi
040			_aNLM _beng _cNLM
100	1		_aGuirguis, Hany R
245	0	0	_aImpact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. _h[electronic resource]
260			_bBritish journal of haematology _cOct 2012
300			_a39-49 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCentral Nervous System Neoplasms _xdrug therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aVincristine _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aCheung, Matthew C
700	1		_aMahrous, Mervat
700	1		_aPiliotis, Eugenia
700	1		_aBerinstein, Neil
700	1		_aImrie, Kevin R
700	1		_aZhang, Liying
700	1		_aBuckstein, Rena
773	0		_tBritish journal of haematology _gvol. 159 _gno. 1 _gp. 39-49
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2012.09247.x _zAvailable from publisher's website
999			_c21989203 _d21989203